Graftys secures funding to develop resorbable biologic materials for orthopedic applications |

Graftys secures funding to develop resorbable biologic materials for orthopedic applications

Graftys


Graftys Completes Third Round of Financing for 4 Million Euros ($5,3 Million), and Adds a New Financial Partner (press release)

Graftys, founded in 2005, is based in Aix en Provence and Nantes (France) and has opened a local office in Chicago in 2009.  The Graftys team (23 employees) develops, manufactures and markets biomaterials and biotechnologies in the field of bone biology. Company technologies provide innovative therapeutic products through bone tissue engineering.

Leave a Reply

Your email address will not be published. Required fields are marked *